Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 2215  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
Year : 2022  |  Volume : 67  |  Issue : 6  |  Page : 732-743

Diagnosis and management of urticaria in Indian settings: Skin allergy research society's guideline-2022

1 From the Department of Dermatology, D Y Patil Hospital, Navi Mumbai, Maharashtra, India
2 Department of Pharmacology, D Y Patil Hospital, Navi Mumbai, Maharashtra, India
3 Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India
4 Department of Dermatology, The Medicity, Medanta Hospital, Gurugram, Haryana, India
5 Department of Dermatology, Apollo Hospital, Chennai, Tamil Nadu, India
6 Department of Dermatology, BJ Medical College, Ahmedabad, Gujarat, India
7 Department of Dermatology, PD Hinduja Hospital, Mumbai, Maharashtra, India
8 Department of Dermatology, Max Super Speciality Hospital, Patparganj, Delhi, India
9 Department of Dermatology, Skin Diseases Centre, Nashik, Maharashtra, India
10 Consultant Dermatologist, Skin Care Centre, Rajajinagar, Bengaluru, Karnataka, India
11 Department of Dermatology, Mallige Hospital, Bengaluru, Karnataka, India
12 Department of Dermatology, Institute of Child Health, Kolkata, West Bengal, India

Correspondence Address:
Abhishek De
Department of Dermatology, Calcutta National Medical College, Flat Number 3 A, Arcadia 1 Dream Park Sonarpur Station Road, Kolkata - 700 103, West Bengal
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijd.ijd_307_22

Rights and Permissions

Urticaria is a common skin disorder. Chronic urticaria, i.e., the presence of symptoms for more than six weeks, is associated with a significant adverse impact on sleep, performance, quality of life, and financial status of the patients. Although several treatment options are available, the condition can be challenging to treat for many clinicians. Several updates have been published on the subject of urticaria and its management since the publication of an updated consensus statement in 2018 by Indian experts. The objective of this consensus statement is to summarize the updates and provide concise information, including classification, diagnosis, and management of urticaria. Understanding and elimination of the underlying eliciting trigger are essential in all possible cases. The goal of pharmacological treatment is to provide symptomatic relief. Second-generation nonsedating H1 antihistamine continue to be recommended as the first-line treatment, the dose of which can be increased up to four times in patients not responding satisfactorily, in the second step. The role of omalizumab, cyclosporine, H2 antihistamines, and other options is also discussed.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded44    
    Comments [Add]    

Recommend this journal